TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31451986

Group type: EXPERIMENTAL
Intervention: AutonoMe automated delivery system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Monarch III injector system
Number of subjects: 40
Study: 31513531

Group type: EXPERIMENTAL
Intervention: Cold compress
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Xyla-P cream
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28086137

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 150

Group type: COMPARATOR
Intervention: Tolperisone
Number of subjects: 150
Study: 25569408

Group type: EXPERIMENTAL
Intervention: IV ketamine (0.5 mg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rectal ketamine (0.5 mg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Local peritonsillar ketamine (2 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: IV tramadol hydrochloride (2 mg/kg)
Number of subjects: 120
Study: 23521578

Group type: EXPERIMENTAL
Intervention: Color change
Number of subjects: 28

Group type: COMPARATOR
Intervention: Rotational motion change
Number of subjects: 28
Study: 22321929

Group type: EXPERIMENTAL
Intervention: Acute hypervolemic hemodilution (AHH) with 6% hydroxyethyl starch solution at 24 ml×kg(‐1)×h(‐1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group receiving compound electrolyte solution at 6 ml×kg(‐1)×h(‐1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acute hypervolemic hemodilution (AHH)
Number of subjects: 80
Study: 18339727

Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT) - six home treatment sessions over 2 months
Number of subjects: 39
Study: 16782687

Group type: EXPERIMENTAL
Intervention: Digitized speech output
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: DECTalk synthesized speech output
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MacinTalk synthesized speech output
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Contextual information (topic cue)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Longer messages (sentences)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sentences
Number of subjects: 90
Study: 15305234

Group type: EXPERIMENTAL
Intervention: DRB1*04 allele
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: DQB1*03 allele
Number of subjects: 91

Group type: COMPARATOR
Intervention: Goitrous form
Number of subjects: 91
Study: 11977294

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-kalium (GIK) mixture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (physiological saline infusion)
Number of subjects: 0
Study: 9042978

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily after initial 1-week triple therapy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo after initial 1-week triple therapy
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1-week low-dose triple therapy (omeprazole 20 mg b.d., clarithromycin 250 mg b.d., metronidazole 400 mg b.d.)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1-week low-dose triple therapy
Number of subjects: 59
Study: 7934983

Group type: EXPERIMENTAL
Intervention: Ketogenic VLCD (615-kcal/d) for 28 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nonketogenic VLCD (615-kcal/d) for 28 days
Number of subjects: 16
Study: 2829958

Group type: EXPERIMENTAL
Intervention: 10 g of fish oil daily containing approximately 1.8 g eicosapentaenoic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isoenergetic amount of olive oil
Number of subjects: 0
Study: 31613144

Group type: EXPERIMENTAL
Intervention: Frankel 2 appliance (FR2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modified Twin Block appliance (MTB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 60
Study: 29560570

Group type: EXPERIMENTAL
Intervention: Monthly injections
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Monthly vaginal ring
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Daily oral tablets
Number of subjects: 277
Study: 29137681

Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-tourniquet group
Number of subjects: 150
Study: 26605710

Group type: EXPERIMENTAL
Intervention: 16-week lifestyle intervention
Number of subjects: 69

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 69
Study: 23557730

Group type: EXPERIMENTAL
Intervention: 21 text messages about skin cancer prevention, skin self-examination, or physical activity (attention control) over one year
Number of subjects: 678

Group type: COMPARATOR
Intervention: Attention control (physical activity messages)
Number of subjects: 678
Study: 21470751

Group type: EXPERIMENTAL
Intervention: Preoperative amoxicillin
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Postoperative amoxicillin
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 19598023

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus irinotecan, fluorouracil and leucovorin (Group A)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Irinotecan, fluorouracil and leucovorin (Group B)
Number of subjects: 62
Study: 16671837

Group type: EXPERIMENTAL
Intervention: Instructional music therapy
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Improvisational music therapy
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both music therapy treatment groups
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 13
Study: 15448423

Group type: EXPERIMENTAL
Intervention: BMF (human milk fortified with trace elements)
Number of subjects: 62

Group type: COMPARATOR
Intervention: FM 85 (human milk without trace elements)
Number of subjects: 62
Study: 12577332

Group type: EXPERIMENTAL
Intervention: Combined transdermal acupoint electric stimulation (TAES) and isoflurane anesthesia
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isoflurane anesthesia
Number of subjects: 42
Study: 9225334

Group type: EXPERIMENTAL
Intervention: Dietary advice and protein-rich supplements
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 87
Study: 8127927

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (36.6 mval)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lithium sulfate (36 mval)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 3163370

Group type: EXPERIMENTAL
Intervention: Incremental dilation with nasopharyngeal airways
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nondilated group
Number of subjects: 44
Study: 31435716

Group type: EXPERIMENTAL
Intervention: Music offered group (+)MO
Number of subjects: 126

Group type: COMPARATOR
Intervention: No music offered group (−)MO
Number of subjects: 126
Study: 30286418

Group type: EXPERIMENTAL
Intervention: Cochlear-sparing intensity-modulated radiotherapy (CS-IMRT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 3-dimensional conformal radiotherapy (3DCRT)
Number of subjects: 110
Study: 27008542

Group type: EXPERIMENTAL
Intervention: D. pteronyssinus subcutaneous allergen immunotherapy (DP-AIT) for 24 months
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: D. pteronyssinus subcutaneous allergen immunotherapy (DP-AIT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 26715038

Group type: EXPERIMENTAL
Intervention: Web-based self-management programme (HeLP-Diabetes)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Simple information website (Control)
Number of subjects: 350
Study: 23021996

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 2751

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2751

Group type: EXPERIMENTAL
Intervention: Dutasteride and Placebo
Number of subjects: 2751
Study: 20470379

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 20 mg/day orally for 2 years
Number of subjects: 433

Group type: COMPARATOR
Intervention: Follow-up alone
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM)
Number of subjects: 433
Study: 18383390

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 539

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study: 22112040

Group type: EXPERIMENTAL
Intervention: New designed forearm orthosis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Counterforce orthosis
Number of subjects: 24
Study: 16100773

Group type: EXPERIMENTAL
Intervention: DLE skin samples
Number of subjects: 70
Study: 12426515

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water
Number of subjects: 12

Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 12
Study: 9856522

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination (5 injections of 20 microg each)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Intramuscular vaccination
Number of subjects: 81

Group type: COMPARATOR
Intervention: Subcutaneous vaccination
Number of subjects: 81
Study: 7751414

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion (CSI) of octreotide
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intermittent subcutaneous injection (ISI) of octreotide
Number of subjects: 88
Study: 2236455

Group type: EXPERIMENTAL
Intervention: Mirtazapine (18 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Amitriptyline (111 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (4.6 capsules)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 150
Study: 280956

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash (10 ml at 0.1%)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chlorhexidine in Broxojet (0.0025%)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Broxojet with placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chlorhexidine in Broxojet (0.025%)
Number of subjects: 18
Study: 12375796

Group type: EXPERIMENTAL
Intervention: Irinotecan (CPT‐11, Camptosar)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irinotecan in combination with radiation therapy
Number of subjects: 0
Study: 31537189

Group type: EXPERIMENTAL
Intervention: Intravenous glibenclamide
Number of subjects: 264
Study: 29136538

Group type: EXPERIMENTAL
Intervention: Muscular coordination training for two weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 30
Study: 26376822

Group type: EXPERIMENTAL
Intervention: Immediate loop excision
Number of subjects: 1515

Group type: COMPARATOR
Intervention: Punch biopsies with recall for treatment if CIN2/3 confirmed
Number of subjects: 1515

Group type: COMPARATOR
Intervention: Punch biopsies
Number of subjects: 1515
Study: 24989152

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy informed psychotherapy (CBT-ip) only
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: CBT-ip with medication (sertraline)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Medication (sertraline) only
Number of subjects: 34

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 34
Study: 22248710

Group type: EXPERIMENTAL
Intervention: SC symbol
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Modified SC symbol with serving size information
Number of subjects: 216

Group type: COMPARATOR
Intervention: No label
Number of subjects: 216
Study: 20560365

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique (US group)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Nerve stimulation technique (NS group)
Number of subjects: 37
Study: 18029489

Group type: EXPERIMENTAL
Intervention: Almonds (84 g daily for 4 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pork (120 g daily for 4 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pork (same serving as control)
Number of subjects: 60
Study: 16148184

Group type: EXPERIMENTAL
Intervention: Antibodies in lymphocyte supernatant (ALS) assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antibody‐secreting cell (ASC) assay
Number of subjects: 0
Study: 12548198

Group type: EXPERIMENTAL
Intervention: Closed drainage system (Group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: No drainage (Group B)
Number of subjects: 72
Study: 10376852

Group type: EXPERIMENTAL
Intervention: moexipril 15 mg
Number of subjects: 95

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 95
Study: 8777097

Group type: COMPARATOR
Intervention: 0.9% saline (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous i.v. infusion of insulin (1.25 u. h‐1) (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Insulin 10 u. i.v. boluses every 2 h (Group C)
Number of subjects: 60
Study: 1984505

Group type: EXPERIMENTAL
Intervention: Glucose administration
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline administration (Control)
Number of subjects: 21
Study: 6190551

Group type: EXPERIMENTAL
Intervention: Intracavitary mustine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intracavitary talc
Number of subjects: 46
Study: 30287297

Group type: EXPERIMENTAL
Intervention: Duplex-guided PTA (DuPTA)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Conventional PTA
Number of subjects: 142
Study: 29427697

Group type: EXPERIMENTAL
Intervention: Oral diabetes medications
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Barriers to medication adherence
Number of subjects: 611
Study: 27018561

Group type: EXPERIMENTAL
Intervention: High-anxiety training (HA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-anxiety training (LA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 0
Study: 24577937

Group type: EXPERIMENTAL
Intervention: Upright sitting posture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Slumped sitting posture
Number of subjects: 30
Study: 22874875

Group type: COMPARATOR
Intervention: Traditional nurse instruction (3 sessions)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 2 session nurse instruction plus DVD
Number of subjects: 88
Study: 21149919

Group type: EXPERIMENTAL
Intervention: fosamprenavir (FPV)/ritonavir
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: lopinavir (LPV)/ritonavir
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (tenofovir disoproxil fumarate and lamivudine)
Number of subjects: 27
Study: 16962652

Group type: EXPERIMENTAL
Intervention: Structured counseling and patient navigation intervention
Number of subjects: 204

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 204
Study: 16265344

Group type: EXPERIMENTAL
Intervention: Raltitrexed-oxaliplatin (arm A): raltitrexed 3 mg m(‐2) followed by oxaliplatin 130 mg m(‐2) on day 1, repeated every 3 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Raltitrexed-irinotecan (arm B): CPT‐11 350 mg m(‐2) followed by raltitrexed 3 mg m(‐2), repeated every 3 weeks
Number of subjects: 94
Study: 12354086

Group type: EXPERIMENTAL
Intervention: Colgate Total(R) (COL)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Parodontax(R) (PAR)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chlorhexamed(R) (0.1%; CHX)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 8
Study: 10200809

Group type: EXPERIMENTAL
Intervention: Twice-weekly, six-month progressive walking programme
Number of subjects: 38
Study: 8706198

Group type: EXPERIMENTAL
Intervention: Sevoflurane (0.65 MAC, 1.3%) with nitrous oxide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoflurane (0.65 MAC, 0.8%) with nitrous oxide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 50
Study: 2357134

Group type: EXPERIMENTAL
Intervention: Long peritoneal lavage (LPL) for 7 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Short peritoneal lavage (SPL) for 2 days
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Long peritoneal lavage (LPL) for 7 days among patients with fluid collections on early CT scan
Number of subjects: 29

Group type: COMPARATOR
Intervention: Short peritoneal lavage (SPL) for 2 days among patients with fluid collections on early CT scan
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Long peritoneal lavage (LPL) for 7 days among patients with five or more positive prognostic signs
Number of subjects: 29

Group type: COMPARATOR
Intervention: Short peritoneal lavage (SPL) for 2 days among patients with five or more positive prognostic signs
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Long peritoneal lavage (LPL) for 7 days compared to other treatments
Number of subjects: 29

Group type: COMPARATOR
Intervention: Other treatments (without lavage or lavage for 2 to 4 days)
Number of subjects: 29
Study: 395629

Group type: EXPERIMENTAL
Intervention: Cimetidine, 400 mg at night
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 58
Study: 31282006

Group type: EXPERIMENTAL
Intervention: liraglutide (3.0 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 29333454

Group type: EXPERIMENTAL
Intervention: In-home VR telerehabilitation (n = 38)
Number of subjects: 76

Group type: COMPARATOR
Intervention: In-clinic sensory integration balance training (SIBT) (n = 38)
Number of subjects: 76
Study: 25296661

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 8.75 mg lozenge
Number of subjects: 402

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 402
Study: 24372992

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg day(‐1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg day(‐1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Aspirin 3.6 g day(‐1)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22738668

Group type: EXPERIMENTAL
Intervention: Next day review (NDR group)
Number of subjects: 291

Group type: COMPARATOR
Intervention: No next day review (NNDR group)
Number of subjects: 291
Study: 19605528

Group type: EXPERIMENTAL
Intervention: Soy protein isolate (SPI) (80 mg/d aglycone isoflavones)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Milk protein isolate (MPI)
Number of subjects: 29
Study: 17478338

Group type: EXPERIMENTAL
Intervention: 10 mg lutein
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 10 mg lutein plus vitamins, minerals, and antioxidants
Number of subjects: 90

Group type: COMPARATOR
Intervention: Maltodextrin placebo
Number of subjects: 90
Study: 15669556

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) vaginal cream (0.625 mg/g) applied once daily on days 1-21 of two 28-day cycles
Number of subjects: 150
Study: 12508134

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock-wave lithotripsy (SWL)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Pneumatic ureteroscopic lithotripsy (URS)
Number of subjects: 390
Study: 10595633

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Pre-menopausal females
Number of subjects: 70
Study: 7599569

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CY) 4 g/m2 alone
Number of subjects: 35

Group type: COMPARATOR
Intervention: Cyclophosphamide (CY) 4 g/m2 followed by GM‐CSF 250 micrograms/m2 or G‐CSF 600 micrograms
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CY) + GM‐CSF
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Post-transplant ANC > = 500 x 10(6)/l
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Post-transplant platelet count > = 50 x 10(6)/l
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Patients with NHL
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Overall patient follow-up
Number of subjects: 35
Study: 1971701

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg ipsapirone (IPS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7261629

Group type: EXPERIMENTAL
Intervention: Clofibrate treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31778366

Group type: EXPERIMENTAL
Intervention: Proportional-assist ventilation (PAV) with flow assist (FA) 40-90% of resistance (Rrs) and volume assist (VA) 40-90% of elastance (Ers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pressure-support ventilation (PSV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing FA level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing VA level
Number of subjects: 0
Study: 28101704

Group type: COMPARATOR
Intervention: Control group (CON) - 17.2 kJ gross energy/g diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High protein group (HP) - 19.4 kJ gross energy/g diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High fat group (HF) - 19.9 kJ gross energy/g diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High carbohydrate group (HC) - 19.1 kJ gross energy/g diet
Number of subjects: 16
Study: 27647058

Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 1270

Group type: COMPARATOR
Intervention: No nicotine patches (usual care)
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 1270

Group type: COMPARATOR
Intervention: No counseling (usual care)
Number of subjects: 1270
Study: 25337269

Group type: EXPERIMENTAL
Intervention: Low oxygen concentration (5%)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Atmospheric oxygen concentration (20%)
Number of subjects: 92
Study: 21559987

Group type: EXPERIMENTAL
Intervention: Vulnamin(®) plus Ca-alginate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ca-alginate alone
Number of subjects: 0
Study: 19485130

Group type: EXPERIMENTAL
Intervention: Right-hemispheric sensitivity to left-sided manipulations in ratings task
Number of subjects: 3

Group type: COMPARATOR
Intervention: Children aged 11-13 years
Number of subjects: 3

Group type: COMPARATOR
Intervention: Children aged 8-10 years
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All age groups
Number of subjects: 3
Study: 17312332

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (12 weekly injections, targeting hemoglobin levels between 120 and 140 g/L)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 15142880

Group type: EXPERIMENTAL
Intervention: Double induction (arm B)
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Timed-sequential induction (arm C)
Number of subjects: 592

Group type: COMPARATOR
Intervention: Control '3 + 7' induction (arm A)
Number of subjects: 592
Study: 12026533

Group type: EXPERIMENTAL
Intervention: Treadmill ECG stress test (ST) in group A
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Measurements of serum P-selectin levels in group B
Number of subjects: 59